Wave Life Sciences, the RNA-drug maker that went from Series A funding to initial public offering in less than a year, has received an equity investment from Pfizer as part of a deal to collaborate with the pharma giant on treating metabolic diseases. Pfizer will pay Wave $40 million up front, and the deal is … Continue reading “Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal”
Category: Boston
East Coast Biotech Roundup: Homology, Biogen, Intellia & More
It’s not a stretch to say that the progress of a gene editing technology known as CRISPR-Cas9 will be one of the most closely watched biotech stories of this decade. And two important developments along that path are taking place over the next two years. 2016 is the year that the first crop of CRISPR … Continue reading “East Coast Biotech Roundup: Homology, Biogen, Intellia & More”
More than a Matter of Appearances: Pharma’s Existential PR Problem
When President Obama forced Pfizer to scrap its proposed $160 billion merger with Allergan, the industry as well as the company emerged as losers in the eyes of the public, despite Pfizer’s credible and constructive position. As Pfizer CEO Ian Read explained in a recent op-ed piece in The Wall Street Journal: Pfizer has long … Continue reading “More than a Matter of Appearances: Pharma’s Existential PR Problem”
Queralt Secures $749,750 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=260d1cc3-efd5-4217-a5cb-030facf1cbda Date 5/5/2016 Company Name Queralt Mailing Address 250 State Street North Haven, CT 06473 USA Company Description Using Queralt’s iQ3 Asset Tracking System, information about critical organizational assets is only a mouse-click away. Our iQ3 Asset Tracking Systems feature a real-time dashboard, a powerful analytics engine, and user-configurable notifications and alerts, … Continue reading “Queralt Secures $749,750 New Round”
1366 Technologies Receives $10,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c312ea1-97b2-462d-90ac-94b112d29abe Date 5/5/2016 Company Name 1366 Technologies Mailing Address 6-8 Preston Court Bedford, MA 01730 USA Company Description Solving Silicon PV’s Cost Barrier – Silicon PV wafers comprise 50% of the cost of a module and limit manufacturers’ cell efficiencies due to bulk quality and surface non-uniformities. 1366’s one-step Direct Wafer™ process … Continue reading “1366 Technologies Receives $10,000,000 New Funding”
Tierion Obtains $1,000,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62bc7699-7ccd-40c9-b051-a186104f3c2f Date 5/5/2016 Company Name Tierion Mailing Address 555 Asylum Ave. Hartford, CT 06105 USA Company Description We’ve developed an open standard called Chainpoint for recording data in the blockchain and generating blockchain receipts. Each receipt contains all the information needed to verify the data without relying on a trusted third party. … Continue reading “Tierion Obtains $1,000,000 Seed Round”
Lumicell Lands $6,769,997 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f45db5f0-224b-4286-9a28-fb0c56271600 Date 5/5/2016 Company Name Lumicell Mailing Address 80 William Street Wellesley, MA 02481 USA Company Description The company is developing a medical device that can detect remaining cancer cells after surgery. Lumicell is addressing the number one challenge in cancer surgery – the need to remove all cancer cells within the … Continue reading “Lumicell Lands $6,769,997 New Financing Round”
Xconomy Launches Robotics and A.I. Channel
At the end of March, Xconomy held a jam-packed event called Robo Madness: The A.I. Explosion. If you were among the roughly 250 people who descended on the Googleplex in the heart of Cambridge’s Kendall Square for the event, you may have heard me note that robotics and artificial intelligence were clearly growing in importance … Continue reading “Xconomy Launches Robotics and A.I. Channel”
Down to Wire on Napa Summit—Get Your Invite to Our May 16-17 Event
It’s getting close to the last call for Xconomy’s invitation-only Napa Summit. We have a star-studded lineup. But there are only a few tickets and hotel rooms left, and the May 16-17 event is coming up fast. So request your invitation right away if you’d like to join us. It all starts with a dinner … Continue reading “Down to Wire on Napa Summit—Get Your Invite to Our May 16-17 Event”
Led By Kayak Vets, GetHuman Will Fight Your Customer Service Battles
The phrase “customer service” sometimes seems like a joke, given all the barriers consumers must overcome to get their questions or problems resolved by big companies. We’ve all been there: Trying to navigate convoluted phone systems to reach an actual human being; twiddling your thumbs while listening to lame hold music; getting bounced from department … Continue reading “Led By Kayak Vets, GetHuman Will Fight Your Customer Service Battles”
A Vision for Boosting the Life Sciences in San Diego and Beyond
The life sciences industry represents a vital piece of San Diego’s innovation economy, contributing $31.8 billion each year in local economic impact—more than defense or even tourism, according to the San Diego Regional Economic Development Corp. Beyond our region, San Diego’s life sciences community is significant for a different reason: Our companies contribute novel healthcare … Continue reading “A Vision for Boosting the Life Sciences in San Diego and Beyond”
Formlabs Buys Pinshape, a 3D Design Marketplace
A bit of consolidation in the 3D-printing market today: Formlabs, a desktop 3D-printer company in Somerville, MA, says it has acquired Pinshape, an online marketplace for 3D designs, based in Vancouver, Canada. No terms of the deal were given, but it’s a fairly small acquisition. Pinshape has eight employees and got started in 2013. Its … Continue reading “Formlabs Buys Pinshape, a 3D Design Marketplace”
Sharpening Neuro Focus, Biogen to Spin Out Hemophilia Biz
Biogen CEO George Scangos has spent the last several years focusing the company’s research efforts on drugs for tough-to-treat neurodegenerative diseases like Alzheimer’s and Parkinson’s. That made the Cambridge, MA-based company’s hemophilia drugs outliers, which is why perhaps it’s no surprise that today the company has announced plans to funnel those drugs into a separate, … Continue reading “Sharpening Neuro Focus, Biogen to Spin Out Hemophilia Biz”
CloudHealth Scoops Up $20M to Expand in IT Management
The shift to cloud computing has created plenty of openings for businesses big and small to help manage cloud infrastructures and analyze the vast amounts of data that companies and organizations are accumulating. One such startup, Boston-based CloudHealth Technologies, has been rising fast. And it’s about to build on its recent momentum, thanks to a … Continue reading “CloudHealth Scoops Up $20M to Expand in IT Management”
Koppel to Leave Biogen, Return to Bain Capital
After a roughly two-year stint running Biogen’s (NASDAQQ: [[ticker:BIIB]]) dealmaking efforts, Adam Koppel is returning to his previous employer, Bain Capital. Koppel, who was named Biogen’s chief strategy officer in 2014, will step down on June 2 and head back to Bain as a managing director, where he’ll make private investments in biotech and life … Continue reading “Koppel to Leave Biogen, Return to Bain Capital”
Homology Medicines Obtains $43,500,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a5ba970-a8cb-4e2a-beac-84ce41d3d8cc Date 5/3/2016 Company Name Homology Medicines Mailing Address 44 Hartwell Avenue Lexington, MA 02421 USA Company Description Homology is a genetic medicines company translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Website http://www.homologymedicines.com Transaction Type Venture Equity Transaction Amount $43,500,000 Transaction … Continue reading “Homology Medicines Obtains $43,500,000 Series A Round”
CloudHealth Receives $20,000,000 Series C Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=490b82b8-c01d-4f72-a02a-c19fed215d57 Date 5/3/2016 Company Name CloudHealth Mailing Address 280 Summer Street 6th Floor Boston, MA 02210 USA Company Description CloudHealth is IT service management for the cloud, enabling policy driven cost, utilization, performance and security optimization and governance. Website http://www.cloudhealthtech.com Transaction Type Venture Equity Transaction Amount $20,000,000 Transaction Round Series C Proceeds … Continue reading “CloudHealth Receives $20,000,000 Series C Financing Round”
Toyota Opens New $1B Autonomous Vehicle Research Hub in Ann Arbor
All anyone in the automotive industry seems to be talking about these days is the race to develop autonomous cars and new mobility applications. The announcement last month of a new $1 billion Toyota vehicle research operation in Ann Arbor, MI, is another significant milestone in Michigan’s quest to lead the nation in the development … Continue reading “Toyota Opens New $1B Autonomous Vehicle Research Hub in Ann Arbor”
Pressured by a Lender, Bind Files for Bankruptcy
Bind Therapeutics was one of the many biotechs to go public amidst the sector’s recent bull run. But while a number of companies have charged forward since, Bind has stumbled, and today, after a lender forced its hand, the company is seeking bankruptcy protection. Cambridge, MA-based Bind (NASDAQ: [[ticker:BIND]]) filed for Chapter 11 protection today, … Continue reading “Pressured by a Lender, Bind Files for Bankruptcy”
With Pillar and Other Newcomers, Boston’s Venture Scene Shifting
The venture capital industry is going through big changes, perhaps nowhere more so than in Boston, its birthplace. Today a new fund is coming out of stealth that speaks to recent trends in startups and VC—and it’s also trying to help unite the entrepreneurial community. The fund is called Pillar, and it has a familiar … Continue reading “With Pillar and Other Newcomers, Boston’s Venture Scene Shifting”
Ransomware: Four Steps to Avoid Becoming the Next Victim
It’s no secret to anyone who’s been paying attention to global business news: over the last few months, ransomware attacks have been plaguing organizations across every vertical and nation. Recent examples include events in the healthcare and legal industries in particular, notably the widely reported attacks on the MedStar Health hospital chain. In the case … Continue reading “Ransomware: Four Steps to Avoid Becoming the Next Victim”
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist
A group of biotech veterans have debuted today a new company, Homology Medicines, with a bold claim that their underlying science is a better version of the gene editing methods, such as CRISPR-Cas9, that have captured the attention of patients, doctors, and scientists looking to treat desperate diseases. The claim is, for now, untested, as … Continue reading “With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist”
Neurala Obtains $1,175,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f444cbf-e811-4a43-a6bc-200624280155 Date 5/2/2016 Company Name Neurala Mailing Address 8 St. Mary’s Street Boston, MA 02215 USA Company Description Neurala develops neural software and hardware for a robot to be trained instead of explicitly programmed to perform tasks. Smarter robots are cheaper to develop, deploy, and reconfigure to execute more than one specialized … Continue reading “Neurala Obtains $1,175,000 New Financing”
Mobiquity Receives $1,050,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a6c3ef3-f522-4fbe-92f2-85d217fc24c2 Date 5/2/2016 Company Name Mobiquity Mailing Address 51 Sawyer Rd. Waltham, MA 02453 USA Company Description Mobiquity is a strategy-led, implementation driven Mobile Computing professional services firm focused on architecting, developing and deploying custom mobile solutions for the Global 2000. Mobiquity offers a broad range of services for clients seeking to … Continue reading “Mobiquity Receives $1,050,000 New Funding Round”
Exinda Networks Lands $10,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=586a04f0-1220-4328-8f12-bb315503c825 Date 5/2/2016 Company Name Exinda Networks Mailing Address 8 Faneuil Hall Marketplace 3rd Floor Boston, MA 02109 USA Company Description Exinda delivers innovative traffic shaping, application acceleration and WAN optimization solutions designed to make business applications perform better. Website http://www.exinda.com Transaction Type Debt Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Exinda Networks Lands $10,000,000 New Financing Round”
6 Boston Tech Deals You Might’ve Missed This Week
Desktop Metal’s $34 million round and Gemvara’s sale to a business owned by Warren Buffett’s company turned heads this past week. Here are several other Boston-area tech deals that flew somewhat under the radar: —Verisk Health, the Waltham, MA-based healthcare data services division of Verisk Analytics (NASDAQ: [[ticker:VRSK]]), is being acquired for $820 million by … Continue reading “6 Boston Tech Deals You Might’ve Missed This Week”
With CRISPR in Humans On The Horizon, Will the Public Back Intellia?
An icy March wind was blowing across the Charles River, but in the laboratory of Intellia Therapeutics, the 1970s soft-rock hit “Summer Breeze” was blasting. Chief scientific officer Tom Barnes apologized. “Usually it’s heavy metal,” he said. He pointed out a window to a local tower, visible over the Cambridge, MA rooftops, rising from a … Continue reading “With CRISPR in Humans On The Horizon, Will the Public Back Intellia?”
From Antivirus to Zero-Day Attack: A Cybersecurity Glossary
Cybersecurity is a rapidly changing field. The arms race between hackers and organizations trying to defend themselves has given rise to a lexicon of epic proportions—and leaders from almost every industry are learning to speak the language. As concepts like antivirus and firewalls have grown old, security-tech companies are selling everything from “advanced threat detection” … Continue reading “From Antivirus to Zero-Day Attack: A Cybersecurity Glossary”
Sales Is Toxic to Innovation
Having had the good fortune to participate in business development and sales in both startups and large companies (Intel and Microsoft), I have arrived at the conclusion that sales is largely detrimental to successfully bringing innovative ideas to market. There is a critical transition from business development to sales, and if made prematurely it will … Continue reading “Sales Is Toxic to Innovation”
CoolChip Technologies Receives $257,340 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce0fa5d8-dcd1-4a78-9e8f-349991870390 Date 4/29/2016 Company Name CoolChip Technologies Mailing Address 28 Dane Street Somerville, MA 02143 USA Company Description Over the last half-century, everything in computing has significantly evolved – everything but the fan-cooler. Thermal management is critical to product performance and longevity, yet fan-coolers remain antiquated and have not kept pace with … Continue reading “CoolChip Technologies Receives $257,340 New Funding Round”
Cytrellis Biosystems Lands New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38c4b511-9a2d-4dd8-a555-69dee24c7399 Date 4/29/2016 Company Name Cytrellis Biosystems Mailing Address 655 Summer St. Boston, MA 02210 USA Company Description Cytrellis Biosystems, Inc. is a clinical stage medical technology company developing a new, proprietary class of aesthetic devices. Website http://www.cytrellis.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “Cytrellis Biosystems Lands New Funding Round”
campusSIMs Obtains $2,500,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8ea38ec8-73bf-4ad3-82b4-7e3f2125757e Date 4/29/2016 Company Name campusSIMs Mailing Address 667 Boylston Boston, MA 02116 USA Company Description campusSIMs has developed technology that enable international students to sign up for their US mobile phone number before coming to the US. Top institutions including Harvard, Georgetown and Stanford offer campusSIMs’ services to their international students. … Continue reading “campusSIMs Obtains $2,500,000 Series A Funding”
SynDevRx Receives $1,103,575 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=698e7480-1ac7-4fe5-9415-d001557e45e6 Date 4/29/2016 Company Name SynDevRx Mailing Address One Broadway 14th Floor Cambridge, MA 02142 USA Company Description Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit … Continue reading “SynDevRx Receives $1,103,575 New Funding Round”
Ionic Downloads $8.5M to Rev Up Business Around Open-Source Software
When trying to build a business on top of free software, step one is attracting a ton of users. Step two is figuring out how to make money. Ionic has successfully checked the first box. Since launching its free, open-source software more than two years ago, more than 4 million developers worldwide have used it … Continue reading “Ionic Downloads $8.5M to Rev Up Business Around Open-Source Software”
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More
In biotech this Monday, all eyes were on an FDA advisory panel in Hyattsville, MD, where a throng of patient advocates some 800 strong gathered in support of approval for an experimental drug for Duchenne muscular dystrophy, a fatal genetic disease with no cure. The results of the hearing didn’t go the way the crowd … Continue reading “East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More”
COP21—The Road Ahead for Sustainability
Last week’s signing of the Paris climate accord successfully returned international efforts on climate change to the media spotlight. As private investors in cleantech startups since 2006, Element 8 members have been following the developments since December very closely. We are notably encouraged about the future of clean technologies in the wake of not just … Continue reading “COP21—The Road Ahead for Sustainability”
Join Maeda, Hillis, Jepsen, & More in Napa May 16-17—Get Your Invite
Carving out time to really ponder the future of our technology landscape can be touch, but it can also be incredibly valuable. And if that time is spent with some of the world’s great innovators, technologists, and investors, all the better. That’s just the opportunity you’ll have at Xconomy’s invitation-only Napa Summit on May 16-17. … Continue reading “Join Maeda, Hillis, Jepsen, & More in Napa May 16-17—Get Your Invite”
erecruit Holdings Lands $10,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cb360d2-fb0e-4b87-8636-cc8e14be0913 Date 4/28/2016 Company Name erecruit Holdings Mailing Address 2 Oliver Street Boston, MA 02109 USA Company Description erecruit is the leading innovator in enterprise staffing software, VMS and onboarding solutions for large staffing firms and employers. Website http://www.erecruit.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds Purposes The … Continue reading “erecruit Holdings Lands $10,000,000 New Financing”
Gemvara, Once a Boston Tech Crown Jewel, Bought by Richline Group
Gemvara, which several years ago was one of Boston’s high-flying consumer tech startups, has been acquired by Richline Group, a Berkshire Hathaway subsidiary. Terms weren’t disclosed in a press release announcing the deal. The news was first reported by BostInno. Gemvara got started in 2006 as Paragon Lake, and its original business enabled shoppers to … Continue reading “Gemvara, Once a Boston Tech Crown Jewel, Bought by Richline Group”
Desktop Metal Grabs $34M to Move Prototype 3D Printers to Market
The stakes just got even higher for Desktop Metal. The Boston-area 3D printing startup burst onto the scene last fall with a nearly $14 million initial funding round from high-profile investors NEA, Kleiner Perkins Caufield Byers, Lux Capital, 3D printing giant Stratasys, and others. Investors poured in the money largely based on faith in the … Continue reading “Desktop Metal Grabs $34M to Move Prototype 3D Printers to Market”
Biogen Taps Pfizer Exec Ehlers to Run R&D
After a roughly year-long search, Biogen (NASDAQ: [[ticker:BIIB]]) has named a replacement for former R&D chief Doug Williams, who left the company last July to run startup Codiak Biosciences. Biogen has hired Michael Ehlers as its executive vice president of R&D, a position he’ll begin late next month. Ehlers will join Biogen from Pfizer, where … Continue reading “Biogen Taps Pfizer Exec Ehlers to Run R&D”
CyberArk-Led Alliance Unites Security Around Privileged Accounts
A new nationwide cybersecurity industry partnership led by CyberArk Software underscores the sector’s increased emphasis on collaboration and unifying software security measures as threats mount around the world. CyberArk (NASDAQ: [[ticker:CYBR]]) today announced the launch of the C3 Alliance, a group of cybersecurity, enterprise software, and other service providers who will integrate into their offerings … Continue reading “CyberArk-Led Alliance Unites Security Around Privileged Accounts”
Led by Ex-Suros Execs, Nico is Out To Change Brain Surgery
Imagine that, heaven forbid, a blood vessel bursts inside your brain, spilling blood and causing pressure to build inside delicate tissues. You’ve just suffered the deadliest kind of stroke, what’s known as an intracerebral hemorrhage. You might think that surgeons would want to try to repair the damage as soon as you get to the … Continue reading “Led by Ex-Suros Execs, Nico is Out To Change Brain Surgery”
Disruptor Beam Garners $2,080,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=792f5a5d-2a20-4759-b304-1377019a3295 Date 4/27/2016 Company Name Disruptor Beam Mailing Address 161 Worcester Road Framingham, MA 01701 USA Company Description Disruptor Beam creates games that transport fans into the universes they long to dwell in. Console game cos like Bioware find it most profitable to leverage millions of existing fans for popular franchises, but … Continue reading “Disruptor Beam Garners $2,080,000 New Funding”
Powerhouse Dynamics Lands $1,778,130 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=495df726-4205-48d8-b1ff-911ed278e312 Date 4/27/2016 Company Name Powerhouse Dynamics Mailing Address 1 Bridge Street Newton, MA 02458 USA Company Description Powerhouse Dynamics provides new, cost-effective energy management solutions for small commercial operations. Website http://www.powerhousedynamics.com Transaction Type Debt Transaction Amount $1,778,130 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 11 investors participated in … Continue reading “Powerhouse Dynamics Lands $1,778,130 New Financing”
A New Coat Makes The Difference in Rapamycin’s Disease Prevention
San Antonio — Drugs that can cure a disease inevitably draw the most attention. But San Antonio, TX-based Rapamycin Holdings is hoping that its drug’s potential to prevent the recurrence of diseases like cancer, among others, will at least draw the interest of a Big Pharma company with money to spend. By 2017, Rapamycin Holdings … Continue reading “A New Coat Makes The Difference in Rapamycin’s Disease Prevention”
Panama Papers Leak: The New Normal?
Imagine if robbing banks were so easy and common that the only headlines were about all the taxes the thieves were avoiding. Cybercrime has become so expected and normal that media coverage of the Panama Papers leak has barely mentioned law firm Mossack Fonseca’s failure to protect its most valuable and sensitive assets: the files … Continue reading “Panama Papers Leak: The New Normal?”
Veering Off Topic With Salsify CEO Jason Purcell
Jason Purcell is the next victim in my ongoing series of quirky conversations with local tech leaders. Purcell heads up Salsify, which makes cloud-based product-content management software for brands and retailers. He co-founded the company in 2012 with Rob Gonzalez and Jeremy Redburn. The trio previously worked together at Cambridge, MA-based Endeca, the enterprise search … Continue reading “Veering Off Topic With Salsify CEO Jason Purcell”
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote
In a close 7-6 vote, a committee of medical experts said today that eteplirsen, a drug to treat Duchenne muscular dystrophy, has not met the bar set by the FDA for approval, which could make the drug the third Duchenne treatment in recent months to face FDA rejection, adding to the frustration of a tight-knit … Continue reading “Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote”
Threat Stack Founder’s New Startup, Komand, Pushes Security Automation
Threat Stack co-founder Jen Andre, who left the company last year, is back with another Boston-area cybersecurity startup called Komand. The Cambridge, MA-based company formed late last year and has received funding from Accomplice, according to Komand’s website. Accomplice’s Chris Lynch and Cort Johnson sit on Komand’s board, along with Andre, the website shows. The … Continue reading “Threat Stack Founder’s New Startup, Komand, Pushes Security Automation”